

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Bill Freese, Center for Food Safety, bfreese@centerforfoodsafety.org
Nathan Donley, Center for Biological Diversity, ndonley@biologicaldiversity.org
George Kimbrell, Center for Food Safety, gkimbrell@centerforfoodsafety.org
No New Dicamba Approval for 2024 Season, 2025 in Doubt
Pesticide-maker Bayer has asked the Environmental Protection Agency (EPA) to re-approve the dangerous pesticide dicamba for use on genetically engineered (GE) cotton and soybeans.
The request comes after two different federal courts vacated the registrations of the drift-prone weedkiller — one in 2020 and the other in February 2024. Dicamba drift has damaged millions of acres, including croplands, home gardens, forests, and even wildlife refuges. Notably, neither EPA nor dicamba registrants appealed the 2024 court decision, which is now final. In an "existing stocks" order, EPA prohibited any sale or distribution of dicamba not already in channels of trade as of February 6th of this year.
Due to a 17-month review of this new application, dicamba use on GE soybeans and cotton may well remain prohibited for the 2025 crop season.
Overall, the proposal is similar to the prior approvals that the courts have twice found to be illegal, with applications still allowed in conditions that favor volatility and widespread damage to crops and the environment. However, unlike the unlawful 2020 approval, for this proposal there will be a notice and comment period, now required by the 2024 court's decision, in which stakeholders can weigh in and tell EPA to reject it.
"EPA has had seven long years of massive drift damage to learn that dicamba cannot be used safely with GE dicamba-resistant crops," said Bill Freese, science director at Center for Food Safety. "Nothing Bayer might say or do can redeem this inherently hazardous GE crop system. EPA must deny this application to spare thousands of farmers further massive losses, and to avert still more rural strife between dicamba users and victims of its rampant drift."
"This is a farce. Virtually nothing in this application addresses the concerns the public and the courts have about this destructive pesticide," said Nathan Donley, environmental health science director at the Center for Biological Diversity. "Bayer's cynical attempt to push through another illegal dicamba approval is obviously terrible for the environment, but it's also bad for farmers, who keep getting jerked around by the promise of another registration that's destined for failure. The EPA should stop this once and for all with a quick, decisive denial."
Bayer has offered some changes in the proposed label language, but these changes would not fix the key issues that have resulted in past calamities. Cotton growers would still be allowed to spray into the heat of summer (until July 30th), when volatility is worst, promising continued massive drift injury wherever cotton is grown. The proposed reductions in the number and amount of annual applications will not have much impact, since growers have historically used far less dicamba than permitted, causing enormous damage nonetheless. While the proposed label for soybeans would bar application after June 12th or crop emergence (whichever comes first), that language is likely to have little practical impact with a GE crop expressly designed for over-the-top use and the potential for spraying into June.
Background
In 2016 Monsanto, which has since been acquired by Bayer, opened the floodgates to massive spraying of dicamba by genetically engineering soybeans and cotton to withstand "over-the-top" spraying of the pesticide. The results have been devastating, with drift damage to millions of acres of non-genetically engineered soybeans as well as to orchards, gardens, trees and other plants on a scale unprecedented in the history of U.S. agriculture.
Dozens of imperiled species, including pollinators like monarch butterflies and rusty patched bumblebees, are also threatened by the pesticide.
The U.S. Department of Agriculture estimates that up to 15 million acres of soybeans have been damaged by dicamba drift. Beekeepers in multiple states have reported sharp drops in honey production due to dicamba drift suppressing the flowering plants their bees need for sustenance.
The pesticide industry encouraged widespread use of the older, more toxic dicamba after over-the-top use of the glyphosate-based product Roundup on crops genetically altered to resist it fueled weed resistance to glyphosate on more than 100 million acres of U.S. cropland.
In 2020 a federal court vacated the EPA's dicamba registration for the first time because of the unprecedented damage the pesticide caused. The court noted that in approving dicamba, the EPA had failed to examine how "dicamba use would tear the social fabric of farming communities." But a mere four months later, the EPA reapproved the pesticide, claiming that new measures would cut down on the damage.
Yet the EPA admitted in a 2021 report that its application restrictions to limit dicamba's harm had failed and the pesticide was continuing to cause massive drift damage to crops.
In February 2024 a federal court vacated the EPA's 2020 re-approval of dicamba. In its decision, the court outlined the massive damage to stakeholders who were deprived of their opportunity to comment. These included growers who do not use over-the-top dicamba and have suffered significant financial losses and states that repeatedly reported landscape-level damage. As a result, the court found "the EPA is unlikely to issue the same registrations" again after taking these stakeholders' concerns into account.
The court also criticized the EPA's assessment of the 2020 registrations' widespread harms. Monsanto and the EPA claimed this over-the-top new use of dicamba would not cause harm because of new restrictions on its use. But the court found the EPA's "circular approach to assessing risk, hinging on its high confidence that control measures will all but eliminate offsite movement, [led] to its corresponding failure to assess costs from offsite movement." And instead, just as independent researchers had warned, the restrictions failed and dicamba continued to vaporize and drift.
Center for Food Safety's mission is to empower people, support farmers, and protect the earth from the harmful impacts of industrial agriculture. Through groundbreaking legal, scientific, and grassroots action, we protect and promote your right to safe food and the environment. CFS's successful legal cases collectively represent a landmark body of case law on food and agricultural issues.
(202) 547-9359"Over and over again, the Trump administration is exposing private Social Security data," said one watchdog group who called the leak of personal information "a goldmine for identity thieves" and other fraudsters.
A newly reported failure of the Trump administration's ability to handle sensitive private information within the social programs it is tasked with operating triggered a fresh wave of anger of the weekend after it came to light that the Social Security numbers of healthcare providers were made public as part of a faulty Medicare portal rollout.
The Washington Post discovered the compromised database and alerted the administration last week, before publishing a story about its discovery on Friday after efforts had been made to protect the sensitive information from further compromise.
According to the Post:
The Centers for Medicare and Medicaid Services (CMS) last year created a directory to help seniors look up which doctors and medical providers accept which insurance plans, framing it as an overdue improvement and part of the Trump administration’s initiative to modernize health care technology.
But a publicly accessible database used to populate the directory contains some of the providers’ Social Security numbers, linked to their names and other identifying information. For at least several weeks, CMS made the database available for public use as part of its data transparency efforts.
While the reporting noted that the files were "not immediately visible to users who [visited] the provider directory," lawmakers and experts said the compromised information would be a treasure trove for fraudsters.
“The more we learn about how the Trump Administration handles the people’s most sensitive data, the clearer their incompetence becomes."
Critics pounced on the new reporting, calling it "yet another mess-up by the Team Trump" and only the latest evidence that the administration cannot and should not be trusted to protect the nation's most successful anti-poverty programs or the sensitive personal data of the American people who entrust the government with that information.
"Over and over again, the Trump administration is exposing private Social Security data," said Social Security Works, an advocacy group that serves as a public watchdog for the nation's social programs.
The compromised database, said the group, "is a goldmine for identity thieves, scammers, and foreign governments. And it is undermining the very foundation of our Social Security system."
"This is a failure by this administration," said Sen. Ruben Gallego (D-Ariz.) in response to the reporting. "Exposing Social Security numbers, whether patients or providers, is unacceptable."
Rep. Richard Neal (D-Mass.), the ranking member on the House committee which overseas the Medicare program, put the onus on his Republican colleagues in Congress.
“The more we learn about how the Trump Administration handles the people’s most sensitive data, the clearer their incompetence becomes,” Neal told the Post in a statement. “Do House Republicans need to see their own data exposed before they do right by their constituents and act?”
In March, as Common Dreams reported at the time, a whistleblower filed a complaint from with the Social Security Administration accusing a former staffer with Trump's Department of Government Efficiency (DOGE), run for a time by right-wing billionaire Elon Musk, of trying to share information from SSA databases with his private employer.
Since the outset of Trump's second term, DOGE's meddling with Social Security and Trump's undermining of the program have been the source of deep anger and concerns by the program's defenders.
In a social media post on Saturday citing the whistleblower allegations from March, Rep. John Larson (D-Conn.) said, "For more than a year, 'DOGE' has been combing through the American people's records. They want to use your data to overturn elections and profit in the private sector. Enough! This administration must be held accountable for this massive data breach!"
On Friday, responding to the Post's new reporting about the compromised database of physicians' private information, Larsen condemned for Republicans for their ongoing and pervasive failures in the face of Trump's malfeasance and incompetence.
DOGE, said Larsen, "has been in your data for more than a year. We just learned that physicians' Social Security numbers were publicly exposed in an online portal launched by ‘DOGE’ officials."
"If this isn't enough for Republicans to act," he asked, "where will they draw the line?"
"Your dignity stands taller than the place you stood, and it will live forever in our memory."
Explosive Media, one of the independent outfits generating the viral videos about the war in Iran, created a short piece on Saturday to honor the American father of two who climbed atop a bridge in the Washington, DC this weekend to demand an end to the conflict.
"In honor of Guido Reichstadter, the man who climbed the Frederick Douglass Memorial Bridge to make his voice of protest heard," the group said in a post alongside the video short. "Your dignity stands taller than the place you stood, and it will live forever in our memory."
As Common Dreams reported, Reichstadter climbed the bridge wearing a t-shirt that simply read "End War" beginning on Friday afternoon, remained in protest overnight, and told one reporter he intends to remain "for a few days at least."
In honor of Guido Reichstadter,
the man who climbed the Frederick Douglass Memorial Bridge to make his voice of protest heard.
Your dignity stands taller than the place you stood,
and it will live forever in our memory. 🫡🏔️ pic.twitter.com/WANYzS7kIh
— Explosive Media (@ExplosiveMediaa) May 2, 2026
Reichstadter said he climbed the 168-foot-tall bridge “because the government of the United States is engaged in acts of mass murder in my name. And I refuse to be complicit in that.”
"The world is proud of you, Guido," Explosive Media said in a separate post on social media. "Soon, side by side, we will celebrate peace and victory together."
"The safety of mifepristone has never actually been in question," said one advocate. "As this case moves towards the US Supreme Court, we will fight until every person has access to the care they need."
A pharmaceutical company which manufactures mifepristone filed an appeal to the US Supreme Court on Saturday asking for emergency relief from the "sweeping and dangerous" lower-court ruling Friday that would prohibit the mailing of the widely used abortion medication nationwide.
Danco Laboratories, which makes the popular drug and is part of ongoing litigation stemming from a legal challenge by the Republican-controlled state of Louisiana, said Friday's ruling by the Fifth Circuit of Appeals—a decision roundly condemned by reproductive rights advocates as an attack on women's health and the right to choose across the country—will cause "tremendous uncertainty" on the "legal status of mifepristone throughout the country” if it goes into effect.
The company further argued that the ruling as it stands leaves medical providers, patients, and pharmacies “all to guess at what is allowed and what is not," whether or not abortion is legal in the state where a patient is trying to obtain it.
The company asked the nation's highest court for an immediate administrative stay to the 5th Circuit's ruling while the challenge to the drug's availability makes its way through lower courts. It also urged the Court to take up the case itself prior to the upcoming summer recess.
According to Politico:
Even a temporary disruption of access to mifepristone will have massive implications. The medication is used in nearly two-thirds of all pregnancy terminations, and a quarter of patients depend on telehealth to obtain them. The ruling also cuts off telemedicine prescription of the drug for non-abortion purposes, such as easing miscarriages.
In the wake of Friday’s ruling, medical and progressive advocacy groups stressed that doctors can still use telehealth to prescribe the other abortion pill — misoprostol. The drug can be used on its own to end pregnancies and carries fewer restrictions because it is used for an array of other purposes, including treating ulcers and stopping hemorrhages.
Skye Perryman, president and CEO of Democracy Forward who also the legal effort to make mifepristone available by mail during the COVID-19 pandemic as then-Chief Legal Officer and General Counsel of the American College of Obstetricians and Gynecologists, issued the following statement
“Women’s ability to access mifepristone through the mail or from their pharmacy has revolutionized access to care. Now, as anti-abortion extremists seek to employ their anti-abortion playbook and reverse this hard-fought victory for patients, this decision needlessly blocks people around the country from critical healthcare, discriminating in particular against those who live in rural and other areas where healthcare is inaccessible.
"Here's what is very clear: mifepristone has an OUTSTANDING safety record," said the Center for Reproductive Rights on Saturday. "It has been FDA-approved for 25 years and used by more than 7 million people."
Following Friday night's ruling by the 5th Circuit, Mini Timmaraju, president and CEO of the advocacy group Reproductive Freedom for All, said the stakes could night be higher for the right to choose in the United States.
"The court’s decision moves us one step closer to a national abortion ban," Timmaraju warned.
"It is now much more difficult for people to access abortion care," she said. "Anti-abortion politicians know their policies are unpopular, so they are using every lever of government they can. Louisiana built this case on debunked, junk science. The safety of mifepristone has never actually been in question. As this case moves towards the US Supreme Court, we will fight until every person has access to the care they need."